ECEHH appoints new director
Professor Lora Fleming is a leading expert in the environment and public health
Michael Depledge, who has been interim director, will continue in his role as chairman of the advisory board.
Fleming joins ECEHH from the University of Miami where she was a professor in both the medical and marine schools, with particular interests in environmental and occupational health and epidemiology.
She has also held senior roles in the Division of Marine Biology and Fisheries at the Rosenstiel School of Marine and Atmospheric Sciences; the Department of Epidemiology in the Department of Epidemiology and Public Health at the Miller School of Medicine; the University of Miami Oceans and Human Health Center; and the Florida Cancer Data System,.
ECEHH is an initiative of the Peninsula College of Medicine and Dentistry – a joint venture of the University of Exeter and the University of Plymouth in the UK and the NHS in the South West of England – with investment from the ERDF (European Regional Development Fund) Convergence Programme.
ECEHH develops international research to investigate the complex and interactive relationships between the environment and human health. The research takes place within Cornwall from the expanded Knowledge Spa at Treliske and in laboratory-based facilities co-located with the University of Exeter’s Environment and Sustainability Institute, which will be built at Tremough, with collaborations with other research institutions around the world.
The ECEHH focuses on three key themes: the first investigates the effects of chemicals in the environment on human health, including pharmaceuticals and nanomaterials.
The second is climate, oceans and human health. Although the ECEHH looks at climate, oceans and human health globally, it also works on threats in a broader context and of special significance to the coastal communities of Cornwall. These include climate change, the acidification of the oceans and the threat caused by the invasion of species from other regions, such as jellyfish and toxic algae.
The third is clinical photo-biology, and is a continuation and expansion of research already taking place in Cornwall. Research in this area investigates the affects of UV on the skin, and how UVA and pollutants (such as radon and arsenic) interact and influence health.
Fleming said: ‘Our work will help to anticipate and prevent problems, mitigate problems where they do occur, discover new opportunities for businesses, county government and NGOs, and investigate ways in which we can interact with the environment in a positive way.’
You may also like
Research & Development
Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform
Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic partner in validating its computational platform for adeno-associated virus vector optimisation through laboratory testing
Research & Development
Phesi analysis finds 6.7% of global clinical trials affected by Middle East disruption
A Phesi analysis of more than 65,000 active clinical trials has found that 4361 studies are impacted by Middle East disruption, with Phase III oncology trials most exposed and all top ten global pharma companies holding significant investigator site presence in affected countries
Manufacturing
Degasser for volatile and aggressive solvents
Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique degasser is fully compatible with a wide range of volatile and aggressive liquids including Hexafluoroisopropanol (HFIP) and silanes but can also manage all other solvents used for GPC/SEC and HPLC
Research & Development
Symeres joins forces with Ambagon Therapeutics to expand molecular glue research in colorectal cancer
The pair will aim to explore a new class of small molecules, known as molecular glues, for potential therapeutic use in colorectal cancer and other hard-to-target diseases as an alternative to traditional therapies
Research & Development
University of Exeter leads £4.5m Wellcome-funded initiative to develop bioimaging tools for fungal pathogens
An international collaboration spanning the universities of Exeter, Edinburgh and Cape Town has secured £4.5m to develop specialist bioimaging tools for WHO-priority fungal pathogens